Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis-Reference-Cited by-同舟云学术

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

Published:2020-07-02 Issue:8 Volume:61 Page:1823-1832
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Fox María Laura¹²^ORCID,García-Cadenas Irene³⁴^ORCID,Pérez Ariadna Martínez⁵,Villacampa Guillermo⁶^ORCID,Piñana José Luis⁷^ORCID,Ortí Guillermo¹²,Montoro Juan⁷^ORCID,Roldán Elisa¹²^ORCID,Bosch Vilaseca Anna³⁴,Martino Rodrigo³⁴^ORCID,Salamero Olga¹²^ORCID,Saavedra Silvana³⁴,Hernandez-Boluda Juan Carlos⁵^ORCID,Esquirol Albert³⁴^ORCID,Sierra Jordi³⁴^ORCID,Sanz Jaime⁷^ORCID,Solano Carlos⁵^ORCID,Bosch Francesc¹²^ORCID,Barba Pere¹²^ORCID,Valcarcel David¹²^ORCID

Affiliation:

1. Department of Hematology, Hospital Universitari Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

2. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

3. Department of Hematology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant-Pau), Barcelona, Spain

4. José Carreras Leukemia Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain

5. Department of Hematology, Hospital Clínico Universitario- INCLIVA. University of Valencia, Valencia, Spain

6. Oncology Data Science (ODysSey) Group, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

7. Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain – CIBERONC, Instituto Carlos III, Madrid, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1788015

Reference40 articles.

1. Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective

2. Promising Role of Reduced-Toxicity Hematopoietic Stem Cell Transplantation (PART-I)

3. Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

4. Do different conditioning regimens really make a difference?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia;Frontiers in Pediatrics;2021-12-10